» Articles » PMID: 23966140

Chester Step Test: Assessment of Functional Capacity and Magnitude of Cardiorespiratory Response in Patients with COPD and Healthy Subjects

Overview
Date 2013 Aug 23
PMID 23966140
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: the assessment of functional capacity in patients with chronic obstructive pulmonary disease (COPD) has been performed by simple and easy to apply methods that mimic everyday activities, such as the Chester step test (TChester).

Objectives: to investigate whether TChester is able to differentiate functional capacity and the magnitude of cardiorespiratory response of patients with COPD from healthy subjects; and to compare it with the cardiorespiratory response induced by shuttle test (TShuttle) and six-minute walk test (6MWT).

Method: 10 patients with COPD (64±10 years, and forced expiratory volume at the first second - FEV1 38.1±11.8% predicted) and 10 healthy subjects (63±7 years, and FEV1 of 95.8±18.0% predicted) underwent evaluation of pulmonary function, functional status and capacity (6MWT, TShuttle and TChester).

Results: COPD patients had worst performance in all tests, when compared to healthy subjects (TChester 2,1±0,9 vs. 4,1±1,1 completed levels; TC6min: 435±105,1 vs. 593±87,3 m; TShuttle 251±84,6 vs. 436±55,4 m; p<0.05). TChester correlated with TShuttle and 6MWT (r =0.67 and 0.83, respectively, p<0.05). There were no differences in heart rate and dyspnea in TChester levels between groups (p>0.05). SpO2 was lower in COPD patients since the first TChester level (p<0.05).

Conclusion: TChester is valid in the assessment of functional capacity of COPD patients, being able to distinguish them from healthy subjects, inducing similar cardiovascular demand and greater desaturation in COPD patients.

Citing Articles

Clinimetric properties of field exercise tests in cystic fibrosis: a systematic review.

Corda J, Holland A, Tannenbaum E, Cox N Eur Respir Rev. 2024; 33(174).

PMID: 39694588 PMC: 11653197. DOI: 10.1183/16000617.0142-2024.


Comparison of cardiorespiratory parameters between 6-minute walk test and 1-minute sit to stand test in young adults with post-COVID-19: follow-up 3 months.

Amput P, Poncumhak P, Konsanit S, Wongphon S J Thorac Dis. 2024; 16(5):3085-3095.

PMID: 38883677 PMC: 11170376. DOI: 10.21037/jtd-24-44.


Smartphone-based inertial measurements during Chester step test as a predictor of length of hospital stay in abdominopelvic cancer postoperative period: a prospective cohort study.

Nascimento A, Nagata L, Almeida M, Costa V, de Marin A, Tavares V World J Surg Oncol. 2024; 22(1):71.

PMID: 38419082 PMC: 10900612. DOI: 10.1186/s12957-024-03337-1.


The Chester Step Test Is a Reproducible Tool to Assess Exercise Capacity and Exertional Desaturation in Post-COVID-19 Patients.

Peroy-Badal R, Sevillano-Castano A, Nunez-Cortes R, Garcia-Fernandez P, Torres-Castro R, Vilaro J Healthcare (Basel). 2023; 11(1).

PMID: 36611511 PMC: 9819391. DOI: 10.3390/healthcare11010051.


Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease.

Vilarinho R, Serra L, Aguas A, Alves C, Silva P, Caneiras C BMJ Open Respir Res. 2022; 9(1).

PMID: 35387847 PMC: 8987783. DOI: 10.1136/bmjresp-2021-001158.